Ölgerðin Egill Skallagrímsson (OLGERD) Q3 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2026 earnings summary
18 Dec, 2025Executive summary
Group sales increased by 7.3% in Q3 2025 year-over-year, with EBITDA up 8.6% and net profit after tax rising by 3 million ISK compared to the same quarter last year.
For the first nine months of 2025, group sales rose 4.1% year-over-year, but EBITDA was slightly down by 30 million ISK and net profit after tax decreased by 8% compared to the prior year.
Domestic operations delivered 7% higher EBITDA and 6% higher net profit after tax year-over-year for the nine-month period.
Financial highlights
Q3 2025 EBITDA reached 1,260 million ISK, up 9% year-over-year; EBIT was 952 million ISK, up 9%.
Net profit after tax for Q3 was 571 million ISK, a 1% increase year-over-year.
For the first nine months, EBITDA was 3,842 million ISK (down 1% year-over-year), and net profit after tax was 1,825 million ISK (down 8%).
Sales to alcohol stores grew 10% year-over-year in Q3, with supermarket sales up 12% and Horeca up 2%.
Outlook and guidance
Full-year EBITDA guidance raised to 5,000–5,200 million ISK, reflecting the inclusion of Gæðabakstur and Kjarnavörur from December 2025, offset by weaker outlook for Iceland Spring.
Iceland Spring's annual EBITDA is expected to be 300 million ISK below initial forecasts due to direct and indirect impacts of US tariffs.
Cost reductions and market focus planned for Collab exports in 2026, with expansion to one new market.
Latest events from Ölgerðin Egill Skallagrímsson
- 2024 saw stable revenue, lower profit, and strategic moves for future growth.OLGERD
Q4 202518 Dec 2025 - EBITDA and profit declined on flat sales, but equity and strategic investments increased.OLGERD
Q2 202518 Dec 2025 - Sales grew 3.3% but EBITDA fell 8%; guidance unchanged amid acquisitions and new launches.OLGERD
Q1 202625 Nov 2025 - Revenue up 2% but net profit down sharply; focus on sustainability and new products.OLGERD
Q1 202525 Nov 2025 - EBITDA and profit fell on higher costs, but assets and equity grew amid key investments.OLGERD
Q3 202525 Nov 2025 - Revenue up 2.7% year-over-year, but EBITDA and net profit declined on higher costs.OLGERD
Q2 202612 Oct 2025